Clinical Trials Directory

Trials / Completed

CompletedNCT04806386

The Role of Fiber in the Prevention and Treatment of Fecal Incontinence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
Female
Age
50 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effect of fiber supplementation on the fecal metagenome and metabolome in relation to symptoms and anorectal physiology in post-menopausal women with irritable bowel syndrome with diarrhea suffering from liquid stool fecal incontinence (FI.)

Detailed description

This is an open-label, single-arm study at Massachusetts General Hospital that aims to recruit post-menopausal female patients with solid stool fecal incontinence. The investigators hope that subjects taking a daily fiber supplement will experience reduced episodes and symptoms of fecal incontinence, measured through quality of life questionnaires and daily stool and food diaries. Subjects will undergo 2 anorectal manometry procedures. Stool samples will also be collected for metabolomic and metagenomic analysis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPsylliumPsyllium fiber powder baked into a bar is commonly used as a first line of treatment for patients with fecal incontinence.

Timeline

Start date
2021-07-21
Primary completion
2024-12-11
Completion
2024-12-11
First posted
2021-03-19
Last updated
2025-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04806386. Inclusion in this directory is not an endorsement.